Guy M. Lenk

Guy M. Lenk

Auto-generated profile, based on publicly available information

Guy M. Lenk

Department of Human Genetics, University of Michigan, Ann Arbor, Michigan, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2008 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AHAnna Helgadottir
Anna Helgadottir
GTGudmar Thorleifsson
Gudmar Thorleifsson
KMKristinn Magnússon
Kristinn Magnússon
SGSolveig Grétarsdottir
Solveig Grétarsdottir
VSValgerdur Steinthorsdottir
Valgerdur Steinthorsdottir
KSKari Stefansson
Kari Stefansson

1 January 2009 in The American Journal of Human Genetics
Verified
Journal Article
Open access
CCClement Y. Chow
Clement Y. Chow
JLJohn E. Landers
John E. Landers
SBSarah K. Bergren
Sarah K. Bergren
PSPeter C. Sapp
Peter C. Sapp
AGAdrienne E. Grant
Adrienne E. Grant
MMMiriam H. Meisler
Miriam H. Meisler
Mutations of the lipid phosphatase FIG4 that regulates PI(3,5)P(2) are responsible for the recessive peripheral-nerve disorder CMT4J. We now describe nonsynonymous variants of FIG4 in 2% (9/473) of patients with amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS). Heterozygosity for a deleterious allele of FIG4 appears to be a risk factor for ALS and PLS, extending the list of known ALS genes and increasing the clinical spectrum of FIG4-related diseases.

1 September 2013 in Developmental Cell
Verified
Journal Article
Closed access
MSMohammad Samie
Mohammad Samie
XWXiang Wang
Xiang Wang
XZXiaoli Zhang
Xiaoli Zhang
AGAndrew Goschka
Andrew Goschka
XLXinran Li
Xinran Li
HXHaoxing Xu
Haoxing Xu

9 October 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
SZSergey N. Zolov
Sergey N. Zolov
Dave  BridgesDave Bridges
Dave Bridges
YZYanling Zhang
Yanling Zhang
WLWei-Wei Lee
Wei-Wei Lee
EREllen Riehle
Ellen Riehle
LWLois S. Weisman
Lois S. Weisman
Mutations that cause defects in levels of the signaling lipid phosphatidylinositol 3,5-bisphosphate [PI(3,5)P 2 ] lead to profound neurodegeneration in mice. Moreover, mutations in human FIG4 predicted to lower PI(3,5)P 2 levels underlie Charcot–Marie–Tooth type 4J neuropathy and are present in selected cases of amyotrophic lateral sclerosis. In yeast and mammals, PI(3,5)P 2 is generated by a protein complex that includes the lipid kinase Fab1/Pikfyve, the scaffolding protein Vac14, and the lipid phosphatase Fig4. Fibroblasts cultured from Vac14 −/− and Fig4 −/− mouse mutants have a 50% reduction in the levels of PI(3,5)P 2 , suggesting that there may be PIKfyve-independent pathways that generate this lipid. Here, we characterize a Pikfyve gene-trap mouse ( Pikfyve β -geo/ β -geo ), a hypomorph with ∼10% of the normal level of Pikfyve protein. shRNA silencing of the residual Pikfyve transcript in fibroblasts demonstrated that Pikfyve is required to generate all of the PI(3,5)P 2 pool. Surprisingly, Pikfyve also is responsible for nearly all of the phosphatidylinositol-5-phosphate (PI5P) pool. We show that PI5P is generated directly from PI(3,5)P 2 , likely via 3′-phosphatase activity. Analysis of tissues from the Pikfyve β -geo/ β -geo mouse mutants reveals that Pikfyve is critical in neural tissues, heart, lung, kidney, thymus, and spleen. Thus, PI(3,5)P 2 and PI5P have major roles in multiple organs. Understanding the regulation of these lipids may provide insights into therapies for multiple diseases.

16 July 2007 in BMC Genomics
Verified
Journal Article
Open access
PDF file
GLGuy M Lenk
Guy M Lenk
GTGerard Tromp
Gerard Tromp
SWShantel Weinsheimer
Shantel Weinsheimer
ZGZoran Gatalica
Zoran Gatalica
RBRamon Berguer
Ramon Berguer
HKHelena Kuivaniemi
Helena Kuivaniemi
Background: Abdominal aortic aneurysms are a common disorder with an incompletely understood etiology. We used Illumina and Affymetrix microarray platforms to generate global gene expression profiles for both aneurysmal (AAA) and non-aneurysmal abdominal aorta, and identified genes that were significantly differentially expressed between cases and controls.Results: Affymetrix and Illumina arrays included 18,057 genes in common; 11,542 (64%) of these genes were considered to be expressed in either aneurysmal or normal abdominal aorta. There were 3,274 differentially expressed genes with a false discovery rate (FDR) ≤ 0.05. Many of these genes were not previously known to be involved in AAA, includingSOSTandRUNX3, which were confirmed using Q-RT-PCR (Pearson correlation coefficient for microarray and Q-RT-PCR data = 0.89; p-values for differences in expression between AAA and controls forSOST: 4.87 × 10-4and forRUNX3: 4.33 × 10-5). Analysis of biological pathways, including Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG), indicated extreme overrepresentation of immune related categories. The enriched categories included the GO category Immune Response (GO:0006955; FDR = 2.1 × 10-14), and the KEGG pathwaysnatural killer cell mediated cytotoxicity(hsa04650; FDR = 5.9 × 10-6) andleukocyte transendothelial migration(hsa04670; FDR = 1.1 × 10-5).Conclusion: Previous studies have provided evidence for the involvement of the immune system in AAA. The current expression analysis extends these findings by demonstrating broad coordinate gene expression in immunological pathways. A large number of genes involved in immune function were differentially expressed in AAA, and the pathway analysis gave these results a biological context. The data provide valuable insight for future studies to dissect the pathogenesis of human AAA. These pathways might also be used as targets for the development of therapeutic agents for AAA.

29 September 2009 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
CFCole J. Ferguson
Cole J. Ferguson
GLGuy M. Lenk
Guy M. Lenk
MMMiriam H. Meisler
Miriam H. Meisler
Mutations affecting the conversion of PI3P to the signaling lipid PI(3,5)P2 result in spongiform degeneration of mouse brain and are associated with the human disorders Charcot–Marie–Tooth disease and amyotrophic lateral sclerosis (ALS). We now report accumulation of the proteins LC3-II, p62 and LAMP-2 in neurons and astrocytes of mice with mutations in two components of the PI(3,5)P2 regulatory complex, Fig4 and Vac14. Cytoplasmic inclusion bodies containing p62 and ubiquinated proteins are present in regions of the mutant brain that undergo degeneration. Co-localization of p62 and LAMP-2 in affected cells indicates that formation or recycling of the autolysosome is impaired. These results establish a role for PI(3,5)P2 in autophagy in the mammalian central nervous system (CNS) and demonstrate that mutations affecting PI(3,5)P2 can contribute to inclusion body disease.